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ABSTRACT

Around the world, governments are coping with spiraling health care spending. This
spurs the need for further insight in the determinants of such expenditures. This study
investigates the determinants of health care expenditures for a sample of thirty five
countries in the Organization for Economic Cooperation and Development (OECD) from
2000 to 2013 in order to understand the impact of different factors on health care
spending growth. Besides Gross Domestic Product (GDP), the study accounts for many
different driving forces such as demographics, medical progress, health system
characteristics, public financing, and other non-medical determinants of health spending
such as alcohol and tobacco consumption. Fixed and random-effects panel data models
were used to examine the factors influencing health care expenditures and their results are
compared.

JEL Classification: I10, I11, I12, I14, I18
Keywords: Income Elasticity; Health, Physician, Mortality, Public Health; OECD
Countries
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1.0

INTRODUCTION
Over the last few decades, health care expenditures1 have been rising faster than

overall economic growth in most developed countries and almost all countries have seen
their health care spending increase as a proportion of Gross Domestic Product (GDP) over
time (Figure 1). Especially in the U.S., total expenditures on health as a percent of GDP has
risen from 12.51% in 2000 to 16.39% in 2010. However, the growth has come to a halt in
the wake of the 2008 financial crisis. On average, health spending as a share of GDP rose
from 6.43% in 2000 to 7.99% in 2011 in OECD (Organization for Economic Cooperation
and Development) countries (“OECD Health Statistics”, 2016).

Figure 1: Total Expenditures on Health as Percent of GDP
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In this paper, health (care) expenditures and health (care) spending are used as synonyms.
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There are a great number of factors contributing to the increase in health spending
levels in all developed countries. Those determinants of health expenditures include GDP
growth, life expectancy, infant mortality, medical progress, technological improvement,
public financing, population aging, alcohol consumption, tobacco consumption, and so on.
While the majority of the research on health care expenditures has mentioned those factors,
the method of study is still limited. Cross-sectional data could lead to potential bias of the
measures of outcome with regards to capturing time-related problems. Moreover, crosssectional studies have also raised some statistical and methodological problems when trying
to figure out whether health care is a necessity or a luxury good. In those studies that utilize
the time series technique, the problem of stationary and non-stationary variables are not
always satisfactorily determined, therefore leading to the issue of deterministic trend,
outliers, and heteroskedasticity. Moreover, there are few studies that cover the most recent
period.
This paper makes progress in several aspects. First, it covers the current health care
expenditures in the recent period from 2000 to 2013. Second, it avoids the inconvenience
and weaknesses of time series and cross-sectional data by using panel data to analyze the
dynamic relationship between health spending and various independent variables. This
research will test the hypothesis that several important factors such as GDP per capita, life
expectancy, public financing, and population aging, etc. would have a great impact on health
care expenditures in OECD countries in the past few years.
From a policy perspective, this study is important as the determinants of health
expenditures receive a lot of attention from policy makers, researchers, and politicians as the
rapid growth of health expenditures has become a grave concern for both households and
governments. The ultimate goal of this study is to observe different comparable variables
and their significance in determining the level of health care expenditures in 35 OECD
countries from 2000 to 2013.
The rest of the paper is organized as follows: section 2 discusses the current health
care trends. Next, section 3 presents a literature review and the fourth one describes the
database and empirical methodology. Section 5 explains the empirical findings, followed by
conclusions in section 6. Finally, this paper ends with the appendices and references.
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2.0 CURRENT TRENDS
2.1 Current Trend in Health Care Expenditures
In 2013, the United States outspent all other OECD countries by a wide margin, with
an equivalent of $8,713 per person annually (Figure 2). This number is more than twice the
OECD’s average of $3,453 and nearly 40% higher than that of Switzerland, the second
biggest spender, with $6,325. Compared with Turkey, the lowest spender among OECD
countries, the United States spent more than nine times on health care for each US resident.
Compared with some G7 countries, the U.S. spent around twice as much as other countries
like Germany, France, and Canada did.
Figure 2 also shows how public and private sources are allocated in each country.
Public health care expenditures in the United States still remain the highest among all
OECD countries. Meanwhile, the U.S. private sector plays an even bigger role in financing
its health care system.

Figure 2: Health Expenditure per Capita, 2013
USD PPP
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Source: OECD Health Statistics 2015; WHO Global Health Expenditure Database.

There have been some significant changes in the annual growth rates in per capita
health expenditures before and after the financial crisis. In the Slovak Republic, the annual
health care growth rate has decreased by 10.7% (11.3% vs. 0.6%) after the crisis. In Greece
and Ireland, annual growth rates have been reversed significantly. Only six countries
including Japan, Hungary, Switzerland, Israel, Chile, and Mexico have recorded a higher
level of growth even after the recession.

Figure 3: Annual Average Growth Rate in Health Expenditure per Capita, from 2005
to 2013
Rate (%)
15
2009-2013

5.4
5.9
6.4
2.3
1.3
2.5
1.9
3.6
3.2
3.9

5.0
1.2
1.9
1.2
1.7
1.3
2.3
1.5
3.3
1.7
1.7
1.7
2.9
2.0
2.8
2.0

0.8
1.5
0.9
2.2
1.0
1.7
1.0

0.6

4.1
0.6

3.4
0.6

0.5

3.2
0.3

0.3

3.5

5.4
3.2

3.4
0.4

0.5

1.3

3.5

5

3.6

5.3

5.4

6.7

8.4

10

9.0

11.3

2005-2009

-2.3

-0.1

-0.2

-0.3

-0.4

-0.8

-1.6

-1.7

-3.0

-7.2

-4.3

-5

-4.0

-0.4

0

-10

Since 2000, health care spending growth has always been higher than GDP growth
across many OECD countries (“Health at a Glance 2015: OECD Indicator”, 2015).
Nevertheless, as a result of the financial crisis in 2008, there was a reduction in health
spending to GDP ratio in those countries.
Health care expenditures accounted for 8.9% of GDP on average among all OECD
5
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countries in 2013 (Figure 4), which stayed the same compared to 2012 and up from 8.8%
in 2011. In 2013, the United States remained the highest spender on health care with
16.4% of GDP, outspending more than five percentage points compared to the second
biggest spender groups which include the Netherlands, Switzerland, Sweden, Germany,
and France. Overall, almost half of the OECD countries spent about 9% of GDP on health
care. Meanwhile, Latvia and Turkey spent the least with around 5% of GDP on health
services.
Figure 4: Health Expenditure as a Share of GDP, 2013
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It is clear that health expenditure growth has been aligned to the economic growth
in many OECD countries over the past decade. Government deficits and the economic
crisis are some of the reasons for the drop in health care spending (especially in the public
sector) after 2008 (Figure 5 and 6). Health spending to GDP ratio in the United States has
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remained the same since 2009 in contrast to a steady increase of 2 percentage points in the
period from 2005 to 2009 (Figure 5). Canada’s ratio reached its peak in 2009 and since
then its health spending to GDP ratio flat-lined. Japan, on the other hand, has always
shown a steady increase in the level of health expenditure even amid the slowdown of
economic growth in 2009. This constant rise is the result of a deliberate policy to foster
public health care in Japan (“Health at a Glance 2015: OECD Indicator”, 2015).
Meanwhile, France and Germany have experienced a steady level of health expenditure as
a share of GDP as a result of their stable economy. Other European countries, such as
Ireland and Portugal saw a substantial decline in their health spending to GDP ratio after
2009 (Figure 6). Greece, with its fluctuation in the level of GDP growth and its significant
cuts to health spending over the years, shows some substantial ups and downs in health
spending to GDP ratio.

Figure 5: Health Expenditure as a
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2.2 Current Trends in Determinants of Health Care Expenditures
Across OECD countries, people are living longer than ever before, with life
expectancy now exceeding 80 years on average, thanks to improvements in living
conditions, educational attainments, and most importantly, improvement in health care
(“Health at a Glance 2015: OECD Indicator”, 2015). In most countries, universal health
coverage provides financial protection against the rising cost of illness and promotes access
to health care for the whole population. The quality of health care is also significantly
improved throughout the years, as shown in the reduction of deaths in heart attacks or
improved treatments for serious diseases and cancer. Nevertheless, the improvements come
with cost. Higher health care spending is not a problem if benefits outweigh the costs but
there is ample evidence of inefficiency and ineffectiveness in health care systems.
Health Status
Life expectancy continues to increase steadily in OECD countries, rising on average
by 3 - 4 months each year. In 2013, life expectancy at birth reached 80.5 years of age on
average. Japan, Spain, Switzerland, Italy and France are those countries that have the
highest life expectancy at birth, although France does not perform very well in terms of life
expectancy at birth for men, showing higher mortality rates among younger and middleaged men. On the other hand, Mexico, Hungary, the Slovak Republic and Turkey have the
lowest life expectancy at birth, even though Turkey has achieved huge gains in longevity
over the past few decades and is quickly moving towards the OECD average
Although higher health spending per capita is generally associated with higher life
expectancy, this relationship is less prominent in countries at the highest levels of health
8
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spending per capita. Japan, Spain and Korea stand out as having relatively high life
expectancies, and the United States relatively low life expectancies, given their levels of
health spending (see Figure 7). Life expectancy in the United States is lower than in most
other OECD countries because of higher mortality rates from various health-related
behaviors such as higher obesity rates, higher consumption of drugs, and higher deaths from
road traffic accidents and homicides, adverse socio-economic conditions, and poor access of
care for certain population groups.
Figure 7: Life Expectancy at Birth and Health Spending Per Capita, 2013

Source: OECD Health Statistics 2015
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Health Resources
Higher spending on health care expenditure does not always associate with higher
spending on health resources in terms of physical and technical equipment in health
systems. The number of doctors and nurses has never been higher in OECD countries and
varies widely across OECD countries. According to Figure 8, Greece, Austria, and Norway
have the highest number of physicians per 1000 population in 2013.
The significant increase in the number of doctors is due to a higher number of
foreign-trained doctors working in OECD countries in response to short-term needs and a
surge in student intakes in medical programs. Turkey, Korea, Mexico and the United
Kingdom are those countries with the highest rate of increase in the number of physicians
Figure 8: Physicians per 1000 Population, 2013

Sources: OECD Health Statistics

The number of hospital beds provides the access to health care and therefore
measures the resources available for delivering health services. Among OECD countries,
Japan and Korea have the highest number of hospital beds with more than 11 beds per 1000
population, as seen in Figure 9. These two countries have the “social admissions” in which
a significant part of hospital beds is devoted to long-term care. From 2000 to 2013, the
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number of hospital beds in 35 OECD countries has been decreasing as a result of the
medical progress which allows day surgeon and avoid the need for hospitalization.
Figure 9: Hospital Beds per 1000 population, 2013

Risk Factors of Health
Most OECD countries do not perform well for at least one of the risk factors
affecting health such as tobacco or alcohol consumption. This underlines the importance of
raising awareness among people within the society and of putting higher priority on disease
prevention and health promotion to reduce risk factors to health.
The proportion of daily smoking in adult varies greatly among OECD countries.
According to Figure 10, more than half of OECD countries had less than 20% of the
population smoking daily in 2013. Smoking rates are lowest in Sweden, Iceland, Mexico,
and Australia while smoking prevalence is highest in Greece, Latvia, and Chile. Smoking
rates across most OECD countries have been diminishing over the years in response to
rising rates of tobacco-related diseases and public awareness campaigns.
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Figure 10: Daily Smoking in Adults, 2013

Sources: OECD Health Statistics

On average, alcohol consumption was at 8.9 liters per adult across OECD countries in 2013.
The highest consumption of alcohol was recorded in Austria, Estonia, and Czech Republic
with 11.5 liters per adult annually (Figure 11). Low alcohol consumption was recorded in
Turkey and Israel, where religious and cultural traditions restrict the use of alcohol in some
population groups.
Figure 11: Alcohol Consumption among Adults, 2013

Sources: OECD Health Statistics
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3.0 LITERATURE REVIEW
Previous literature reviews have examined various determinants of aggregate health
care expenditures. They mention the effects of aggregate income, institutional, and sociodemographic factors on health care such as per capita GDP, public financing, proportion of
the population aged 65 and older, and medical progress. By using household or
macroeconomic data, those studies rely on different research methods such as crosssectional, panel, cointegration, and unit root methods, therefore obtaining different
regression results.
Most studies show that income (using per capita GDP as a proxy) is the most
important determinant of aggregate health care expenditures. Since the 1970s, Kleiman
(1974) and Newhouse (1977) have identified the key role of income in explaining the
differences of health care expenditures between countries. Earlier studies focus on income
elasticity of health care and its impact on policy as well as the distribution of health care
resources. Most cross-sectional regressions of aggregate health expenditure per capita on
GDP per capita show that the coefficient estimate of GDP per capita is equal to or greater
than one (Kleiman, 1974; Newhouse, 1977; Leu, 1986; Getzen, 2000), implying that health
care is a luxury. Gerdtham (1992) conducted a study employing 1987 data from 19 OECD
countries. He found per capita income to be one of the most significant determinants of per
capita health expenditures2. The coefficient estimates for per capita income was -1.33,
suggesting that there is income elasticity.
Nevertheless, one would intuitively expect income elasticities to be less than unity,
inferring that health care is seen more as a necessity than a luxury. Much of the later studies
have raised statistical and methodological issues with these cross-sectional approaches by
indicating that health care is not a luxury good, as the inferences in the stationary tests have
suggested (Hansen & King, 1996; Blomqvist & Carter, 1997; McCoskey & Selden, 1998;
Gertham & Lothgren, 2000; Dreger & Reimers, 2005). More recently, a study by Baltagi
and Moscone (2010) indicated that health care elasticity, with respect to income was about
2

The coefficient estimates for urbanization, share of public health expenditure, share of

inpatient care expenditure, and a fee-for-service fixed effect are also statistically significant.
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0.87 in 20 OECD countries over the period 1971-2004. This analysis investigated the nonstationary and cointegration properties in health care spending, income per capita, and their
long-run relationship. Possible reasons for the differences in income elasticity obtained in
previous studies could be attributed to omitted variables bias, small data sets, the issue of
non-stationary variable in health data and income, or the regional dimension of health care
expenditures within a country. The disagreement over the nature of health care therefore has
led to the controversy over health care policy implications. Advocates of health care being a
necessity believe that the government should support the health care system. On the other
hand, people who agree that health care is a luxury believe that government intervention is
unnecessary and that the health care market should be left alone (Culyer, 1988).
However, numerous studies in the past possess some obvious limitations. First, those
studies rely on cross-country data from a single year, therefore making it impossible to
control for unobserved time – specific shocks that simultaneously affect all countries.
Second, the data size for those studies is very small which preclude any benefits from
asymptotic properties and further confound empirical estimates of income elasticity. Third,
omitted variables bias could be a possible reason for the large income elasticities obtained in
previous studies (Sen, 2005). Coefficient estimates of per capita income is biased upwards
because of the absence of any controls for unobserved determinants of per capita health
expenditures, which are time-invariant and time-varying within countries. Therefore,
coefficient estimates of the impact of per capita income will be inflated by an inability to
disentangle actual movements in per capita income from year-specific shocks that are
common across countries.
Another important point that has be taken into consideration in many past studies is
the reverse effects of health care expenditures on GDP (Erdil & Yetkiner, 2009). When
treating health as part of human capital together with education, an increase in health care
expenditures must ultimately lead to a higher GDP. Also, increases in health spending
associated with effective health intervention increases labor supply and productivity,
eventually leading to a higher GDP. This reverse causation makes it difficult to designate a
clear impact of one variable to the other. There might be an endogeneity problem caused by
the simultaneous causal relationship between GDP and health care spending. Several studies
that applied the Granger-causality test (Granger, 1969) showed significant bi-directional
14
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Granger-causality for high income countries. A study by Erdil and Yetkiner (2009)
suggested that a one-way causality run from health care expenditures to GDP in high income
countries. However, the results have been mixed. Another study by Hartwig (2008) showed
no evidence that health spending causes per-capita GDP growth in 21 OECD countries with
a positive sign.
Besides income, other important factors such as non-income determinants such as
demographics, technological progress, and health system characteristics are also taken into
consideration in previous literature. First, the age structure of the population has been seen
as a significant variable in explaining per capita health spending across countries in several
studies (Leu, 1986; Culyer, 1988). Indicators such as the percentage of population ages 65
and over and the percentage of population ages 15 and under have been included in
regression models. According to Murthy (1994) and most of the studies, the share of the
elderly has a positive correlation with future health care expenditure growth. As the elderly
are usually cared for the remainder of their lives, health care expenses increase as well. For
example, in Korea, the “social admissions”, a significant part of health care expenditure, is
devoted to long term care. Therefore, an increase in the percentage of elderly people results
in a more than proportionate increase in health care costs. Other studies also argue that
health care costs often remain constant throughout the senior years and only increase with
proximity to death (Sen, 2005). In both cases, an aging population is expected to impose a
significant burden on health care spending. However, little evidence exists on a significant
level of these variables (Leu, 1986; Hititis and Posnett, 1922; Di Matteo and Di Matteo,
1998; Grossman, 1972). Age distribution shows a relatively modest impact on health cost
compared to the income effect. On the other hand, Barros (1998) discovered that the effect
of aging populations are unable to explain growth rates in health care expenditure. The
percentage of elderly people might be negatively correlated with health expenditures.
Obviously, there have been some mixed results associated with the aging population as a
factor of health care spending.
Very few literature reviews from the past have considered technological progress as
a covariate since the work by Newhouse in 1992 (Newhouse, 1992) which saw
technological advances as an important driver of health care expenditures. This is due to a
lack of reliable data on technological advances and the difficulty of finding a proxy for
15
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changes in technology. In those small number of papers that mention technological progress,
several proxies such as the number of specific medical equipment and surgical procedures
have been considered (Baker & Wheeler, 2000; Weil, 1995; Mohan & Mirmirani, 2005).
R&D spending in the health care sector is also chosen as a proxy for technological change
(Okunade & Murthy, 2002). This study shows that real aggregate health care expenditure
per capita does respond to R&D expenditure. As R&D spending continues to rise at
historical rates and real income rises, health insurance is likely to be more expensive and
therefore drive up health care expenditure. Furthermore, life expectancy and infant mortality
are also common variables that have been widely used for both technological change and
medical progress. The baby boomers are expected to cause a significant increase in health
care costs in many OECD nations. As the baby boomers begin to grow older and life
expectancy rates increase, leading to a surge in health expenditures. Moreover, as infant
mortality has a high correlation with the aging population, infant mortality rates become a
significant factor affecting health care expenditure, granted that the population is healthier.
Thus, life expectancy and infant mortality are two exogenous variables that are major
determinants in the level and growth of health spending, according to Dreger and Reimers
(2005). Additionally, most of these studies use a time trend or a set of time fixed effects as
technological progress changes over time that would help in the absence of a suitable
measure. There are also studies that incorporate different proxies to come up with a better
method of accounting for technological advancement.
Structural characteristics of the health care system such as health financing, the
number of physicians, and the number of hospital beds per capita are also included in
previous studies. The role of government in health care financing has evoked some
controversy over the past few decades. In terms of financing structures, Leu (1986) argued
that the share of public health financing had a positive effect on total health expenditures. In
other words, he stated that health care expenditure should increase with the share of public
finance, under the assumption that this share reduced the price to consumers. Culyer (1988)
continued this line of reasoning by explaining that Leu’s hypothesis came from a passive
response of the financing agent who adjusts the supply of finance to the quantities and prices
of health care. He stressed the degree of open-endedness of financing which plays a bigger
role in health care growth rates and a lack of business restrictions in health care. While
16
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open-ended financing systems are characterized by multiple finance resources such as
different insurance companies and by fee-for-service remuneration, close systems are
characterized by one or few finance agents, global or national budget for hospitals, and
prospective payments such as capitation for outpatient services. Even though the impacts of
the share of public financing and provision on health care expenditure cannot be determined
a priori, countries with more closed financing systems are anticipated to have lower
expenditure. By contrast, Gerdtham et al. (1992) reported that the impact of public financing
in health care cannot be determined as countries with a larger share of public financing do
not seem to be characterized by higher health care expenditure. Thus, public health care has
mixed results on total health care expenditures in previous studies.
Another institutional feature of health systems that may influence health care
expenditures is the fee-for service system which imposes a higher cost on health spending
than other capitation schemes (Gerdtham et al., 1992). Under a fee-for-service system,
physicians may adjust their work load in response to changes in the environment so that
their target income is maintained (Evans, 1974). Hence, a shift from financing hospitals
through budgets to fee-for-services or patient-based payment mechanisms is associated with
increases in both public and private components of health care expenditure.
As mentioned above, the use of physicians or general practitioners as gatekeepers of
the health care system seems to result in higher health expenditure. When the stock of
physicians increases and the work load decreases, physicians tend to induce the patients to
use more services at higher prices (Gerdtham et al., 1992). Moreover, according to Sen
(2005), an increase in salaried physicians can lead to higher per capita health expenditures.
However, he also mentions that an increase in the number of physicians might not have
much impact on health costs under a fee-for-service system if there is a flux of patients from
existing to new practitioners. However, per capita health expenditures will definitely rise if
there is an increase in the number of visits for existing physicians.
Last but not least, another proxy for health resources is the number of hospital beds
per 1000 of population. This exogenous variable captures trends in patient care access in
health care. Even though there are not a lot of studies in the past that use this variable as a
structural characteristic of the health care supply, there exists evidence on restrictions on
17
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hospital bed supply as a component of reducing health expenditures (Vandersteegen, 2014).
Less frequently adopted determinants of health care expenditures are population
density (Hellinger & Encinosa, 2006), urbanization (Gerdtham et al., 1992), the price of
health care (Roberts, 1999), and international aid (Liang & Mirelman, 2014). Furthermore,
Gerdtham et al. (1992) also includes institutional factors in their analysis.
4.0

DATA AND EMPIRICAL METHODOLOGY

4.1

Data and Variables
This study uses data from OECD Health Statistics 2016 to collect panel data from

2000 to 2013 for a sample of 35 OECD countries3. The data set is investigated by estimating
heterogeneous panel model with cross sectional data and comparing its three regression
outcomes that include Ordinary Least Square (OLS), Fixed Effects Model (FEM), and
Random Effects Model (REM). Data were obtained from the World Bank Data Indicators
and OECD Health Database. Independent variables consist of eight variables obtained from
various sources. The list of variables, definitions, and data sources are shown in Appendix
A, while Appendix B provides more details on the variable description, expected signs and
justification for usage. Summary statistics for the data are provided in Table 1.

3

Australia, Austria, Belgium, Canada, Chile, Czech Republic, Denmark, Estonia, Finland, France,
Germany, Greece, Hungary, Iceland, Ireland, Israel, Italy, Japan, Korea, Latvia, Luxembourg, Mexico,
Netherlands, New Zealand, Norway, Poland, Portugal, Slovak Republic, Slovenia, Spain, Sweden,
Switzerland, Turkey, United Kingdom, and United States.
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Table 1. Summary Statistics (N = 490)
Variable

Obs.

Mean

Health expenditures per
Capita (US$)

490

2914.7810

Health Expenditures per
Capita as a Share of GDP
per capita

490

GDP per Capita (US$)

Minimum

Maximum

1523.5760

575.1512

8157.4230

0.0847

0.0196

0.0490

0.1641

490

36508.27

21333.87

6926.75

110001.10

Public Financing (%)

490

71.9351

11.2549

35.9796

89.9983

Number of Physicians per
1000 population

490

2.9831

0.9025

0.8960

6.6167

Number of Hospital Beds
per 1000 population

490

5.2567

2.4211

1.57

14.69

Alcohol Consumption
(Liters per Capita)

490

9.4739

2.7571

1.20

14.80

Tobacco Consumption
(Grams per Person)

490

14.4851

3.3745

6.30

22.00

Life Expectancy (years)

490

78.6545

2.9444

70.10

83.40

Population > 65 years old
(% of total population)

490

14.6407

3.6280

5.0087

25.0093
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4.2

Empirical Models
Following the model provided by Vandersteegen (2014), this study adapted and

modified the model by using some variables from the original regression model and getting
rid of the medical malpractice variable. I have added other variables such as public
financing and several non-medical determinants of health care such as alcohol and tobacco
consumption.
Information is available for the period 2000 – 2013 for all 35 OECD countries,
which yields 490 observations. The data set consists of i = 1,…,N cross sections (number of
groups), and several points of time series for each group t = 1,…,T(i), or a cross section of N
time series each of length T(i). Panel data analysis is divided into fixed effects and random
effects models. FEM looks at the impact of country effects while REM investigates time
effects. In other words, FEM explores the relationship between outcome variables within a
country. In this model, each country has its own individual characteristics that may or may
not influence the predictor variables (for example, government schemes and compulsory
contribution health care financing schemes in a particular country could have some effect on
health care spending). On the other hand, the rationale behind REM is that it considers the
individual effects as a random component of the error term and that variation across entities
is assumed to be uncorrelated with the predictor or independent variables included in the
model.
“The crucial distinction between fixed and random effects is whether the unobserved
individual effect embodies elements that are correlated with the regressors in the
model, not whether these effects are stochastic or not.” (Greene, 2008)

The two models are planned in the following way:
(A) lnPCHCEit = α + β’ (lnPCGDP, PUBFIN, PHYS, BED, ALC, TOB, LIFE, POP65) + uit + εit
(B) (PCHCE / PCGDP)it = α + β’ ( PUBFIN, PHYS, BED, ALC, TOB, LIFE, POP65) + uit + εit
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where i = 1,…,N indicates country
t = 1,…,T(i) indicates year
βi is a vector of coefficients for the vector of the variables
uit is a classical disturbance term with E[uit] = 0, var[uit] = σ2µ
εit is an error term.
In the regression stated above, two endogenous variables are PCHCE and
(PCHCE/PCGDP). While PCHCE controls for per capita total (public and private) health
expenditure, which is measured at purchasing power parity values in US$, (PCHCE /
PCGDP) is per capita health care expenditures as a share of per capita gross domestic
product in US$.
Taking into account the availability and quality of data for the OECD countries and
the findings from past studies, this paper selects several independent variables for the
regression. PCGDP represents Gross Domestic Product (GDP) per capita measured at
purchasing power parity values in US$. GDP is an aggregate measure of production equal to
the sum of the gross values added of all resident institutional units engaged in production.
Other independent variables used in the regression include: proportion of total health care
expenditures that is publicly financed (PUBFIN), which also accounts for a country’s sociopolitical environment, number of physicians per 1000 inhabitants (PHYS), number of
hospital beds per 1000 population (BED), alcohol consumption in liters per person (age 15+)
(ALC), tobacco consumption in grams per person (age 15+) (TOB), life expectancy in years
(LIFE) as a proxy for medical progress, and population age structure (proportion of the
population aged 65 or more) (POP65). Per capita health care expenditures and per capita
GDP are in logs. Variables are in constant prices.
OLS regression is also used to estimate the two models. However, differences in
variances may interfere with the OLS regression method and a robust estimator will be
included in the estimations to account for heteroskedasticity. Standard errors are found in
parentheses estimated coefficients and are White-corrected for heteroskedasticity. All
regressions are estimated using STATA.
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5.0

EMPIRICAL RESULTS
This section presents the results of the regressions, descriptions and explanations

for their significance. The primary goal of this study is to identify the determinants of
health care expenditures in the OECD countries. This paper looks at the dynamic
relationship among different dimensions of health status, from public financing,
demographic references, non-medical determinants of health, to health care resources on
health care expenditures over the period from 2000 to 2013. For each of the exogenous
variables, the interaction is assessed twice to see whether those variables yield the same
result in both models.
All FEM and REM regressions are ran with the same variables as in OLS
regressions. The Hausman Test was used to see whether FEM and REM would be the
more accurate to use with this panel, which will be discussed in the next section. In Table
2, Table 3, Table 4, and Table 5, regression results of the OLS and FEM of health
spending for 35 OECD countries are reported. This study runs different regressions for
each model A and B (all regressions are labeled from 1 to 6).
Based on the regression results, all OLS, FEM, and REM regressions consistently
point to the same direction. Overall, almost all coefficients of our control variables have
the expected sign and are statistically significant except for three variables which are
alcohol consumption, tobacco consumption, and number of hospital beds.
To control for heterogeneity or unobserved effects, Hausman test analysis is
carried out. A Hausman test can be run to determine whether Fixed Effects or Random
Effects model is the most suitable for this study. It is assumed that if the cross-section
specific, error component, and the regressors are uncorrelated, the random effects model
is preferred; otherwise, the fixed effects model is more appropriate. The hypotheses of the
Hausman are as follows:
H0: Random Effects Model
Ha: Fixed Effects Model
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The Hausman test is performed on six regressions as seen in Table 2 and Table 3.
All six regressions suggest that HO should be rejected and therefore a FEM produces
better coefficient estimates. Thus, the FEM turned out to be the best specification.
MODEL A
Using FEM for all three regressions of Model A (regression 1, 2, and 3) in Table 2,
this study points out several factors that help explain the cost of health care, such as GDP
per capita, public financing, life expectancy, and population aged 65 and older. The
estimated coefficients results were expected for three out of eight variables and quite
similar to those reported in other studies. While regression 1 looks at the effect of all
variables on per capita health expenditures, the remaining regressions 2 and 3 allow for
other sensitivity checks. Specially, regressions 2 and 3 consist of empirical estimates in
regression 1 but remove the number of physicians and hospital beds and those non-medical
determinants of health care such as alcohol and tobacco consumption. Furthermore, 82%
(adjusted R-square) of the variation in natural log of per capita health expenditures are
explained by the variation in the model.
The results across all three regressions 1, 2, and 3 are very similar. All of these
regressions indicate that per capita GDP is statistically significant at 1% and the coefficient
estimates for this variable consistently are less than one (0.978 (regression 1), 0.964
(regression 2), and 0.924 (regression 3)). In regression 1, for every additional one percent
increase in log of GDP per capita, there is 0.978% increase in health expenditure per
capita. A t-test performed on these three regressions fails to reject the null (H0: β1 = 1; Ha:
β1 > 1) and therefore suggests that health care is not a luxury good, since it is not
statistically significantly greater than 1. This result backs up the study by Baltagi &
Moscone (2010) which demonstrates that health care is a necessity rather than a luxury,
with an elasticity much smaller than that estimated in previous studies.
In all three regressions 1, 2, and 3, the coefficient estimates of life expectancy
(LIFE) and the percentage of elderly people (POP65) are positive and statistically
significant at alpha levels of 1% and 5%, respectively. There is a strong relationship
between these factors and per capita health expenditures. In regression 1, for every
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additional year of life expectancy, per capita total health expenditures increases by 3.42%,
holding everything else constant. For every additional percentage point of population aged
65 and older, per capita total health expenditures increases by 2.98%, ceteris paribus. From
the demand side perspective, total health care expenditures will increase as there is an
increasing older population. On average, an older population will require more resources
and greater demand for health care. Therefore, higher life expectancy and the aging
population have a great influence on health expenditures.
The empirical estimate of public financing is insignificant in influencing health
expenditures in OECD countries, suggesting that a higher or lower portion of government
schemes and compulsory contributory health care financing schemes has no effect on
reducing the level of health care spending. This finding contradicts Leu’s finding (1986)
that share of public health had a positive effect on total health care expenditures and backs
up Gerdtham’s study (1992) which shows that the impact of public financing in health care
cannot be determined.
Regression 2 attempts to control for the non-medical determinants of per capita
health expenditures which are alcohol consumption (ALC) and tobacco consumption
(TOB). Both of the coefficient estimates for these two variables is statistically insignificant
in all regressions, indicating that alcohol and tobacco consumption do not have an impact
on the level of health care spending in 35 OECD countries from 2000 to 2013.
Regression 3 controls for the impact of health care resources on health spending
throughout the years. The number of physicians per 1000 population (PHYS) as a proxy
for health related human capital does not show any effect on health spending in OECD
countries, as reflected in the coefficient estimate for physician variable. Our regression
results indicate that the number of physicians variable is also insignificant (t = 1.40 in
regression 1 and t = 1.34 in regression 3). Thus, the empirical finding indicates that there is
no evidence of physician supply as influencing health care costs.
Similarly, the number of hospital beds per 1000 population (BED) is statistically
insignificant, indicating that the number of hospital beds is not one of the determinants of
per capita health expenditures. Even though this variable captures trends in patient care
access, which has a similar purpose as the number of physicians (PHYS), there is no
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evidence of the number of hospital beds as a factor that helps reduce health services costs.
The increase in the number of hospital beds does not necessarily imply an increase in the
average length of hospital stay and therefore does not have any impact on total per capita
health expenditures. In contrast to general expectation of hospital services, the number of
hospital beds is not an important cost factor determining the provision of health services.
Even though the main objective of this paper is to examine the determinants of
health care expenditures upon the exogenous variables, a cause-and-effect relationship that
runs from the explanatory variables to the dependent variable is not always the case. For
example, in regressions 1, 2, and 3, GDP per capita can influence the level of health
expenditures per capita, but at the same time, a higher level of health expenditures per capita
can also have a great impact on GDP per capita. As a result, a two-way relationship between
GDP and health expenditures exists. To reduce endogeneity in the models, this research
paper runs the second set of regressions for Model B in which the dependent variable is per
capita health expenditure as a share of per capita income.
MODEL B
As a sensitivity check, three regressions of model B get rid of per capita income
(PCGDP) as an exogenous variable but still control for all other relevant variables that help
explain the level of per capita health expenditures as a share of per capita GDP. Parameter
estimates indicate that these three regressions show similar results to those three regressions
1, 2, and 3 in model A. As discussed earlier, all three regressions 4, 5, and 6 involve FEM
regression, according to Hausman test. Regressions 5 and 6 are variations of regression 4,
providing an interaction between different explanatory variables. These two regressions
consist of sensitivity analyses pertaining to different estimation procedures.
According to the empirical finding, there are two variables affecting per capita
health expenditure as a portion of per capita GDP in those OECD countries. First, the
coefficient estimate of life expectancy (LIFE) is statistically significant at 1% level. This
variable also shows a positive correlation with health expenditure per capita as a percent of
GDP per capita. For every year increase in life expectancy, health expenditures per capita
as a portion of GDP per capita increases by 0.003 percentage point, holding everything
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else constant. Another widely perceived determinant of health expenditure is the ageing
population. The population age structure which is expressed by the share of old people
(above 65 years) over the active or total population (POP65) is significant at 5% level and
positively correlated with trends in health expenditures. Every additional percentage point
of population above 65 years of age lead to the 0.002 percentage point increase in health
expenditure per capita as a share of GDP per capita. A reason for this could be the growing
of baby boomers in many Western nations that eventually leads to an ageing population
and the increase in life expectancy rates. Thus, a significant increase in public health care
expenses as a share of GDP is unavoidable, as the elderly are usually cared for the
remainder of their lives. Therefore, an increase in the percentage of elderly people results
in an unproportioned increase in health care costs, as suggested in a study by Sen (2005).
In terms of financing in health care, the coefficient estimate for public financing is
insignificant (t = -0.44 for regression 4, t = -0.40 for regression 5, and t = -0.41 for
regression 6) to have any impact on health care spending as a portion of GDP in all of the
regressions. As suggested in a study by Gerdtham et al. (1992), public financing in health
care does not have any effect on total health care expenditure as a portion of GDP.
Similarly, both the number of physicians (PHYS) and the number of hospital beds
(BED) are insignificant in determining health care expenditures as a share of GDP, as
suggested by the coefficient estimates for these two exogenous variables. As in model A,
these two variables do not have a big effect on health care even though it is one of the
important factors capturing patient health care access.
Regression 5 focuses on the consequences of including non-medical variables such
as alcohol consumption (ALC) and tobacco consumption (TOB). From the empirical
models, one can see that the magnitude and precision of the coefficient estimates of
alcohol consumption (ALC) and tobacco consumption (TOB) remain unchanged with the
exclusion of other health resources variables (number of physicians per 1000 population
(PHYS) and number of hospital beds (BED)) in regression 4. Statistically there was no
significance for the coefficient estimates of these two variables, indicating that alcohol and
tobacco consumption do not have an impact on health expenditures over years in OECD
countries.
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Lastly, the OLS model was also employed to act as a sensitivity test. These
estimates are contained in Table 4 and Table 5. In model A, the coefficient estimate of per
capita GDP (PCGDP) in OLS regression is quite similar to the corresponding FEM
estimate and is statistically significant. Specifically, the coefficient estimate is significantly
lower than one. Besides life expectancy (LIFE) and population over 65 years old (POP65)
which show the same results as in FEM models, public financing (PUBFIN) and the
number of hospital beds per 1000 of population (BED) are also statistically significant at
1% level in OLS model and both have negative correlation with health care expenditure.
The number of physicians per 1000 of population (PHYS) and alcohol consumption (ALC)
is also at 1% level of significance and have a positive correlation with health care
spending. The only variable that indicates the same result is tobacco consumption (TOB)
which is insignificant in neither the OLS model or FEM method. The important point is
that the OLS models differ significantly from the FEM models by making a numerous
number of variables become significant.
Table 5 shows OLS regression for model B. One could notice a difference between
OLS and FEM method in Table 3 as public financing (PUBFIN), physicians per 1000
(PHYS), and alcohol consumption (ALC) now become significant at 1% level in OLS
model.
Regardless of the number of studies in literature who have used the OLS method,
placing emphasis on results from OLS coefficient estimates could be a misguided strategy
because it might yield simultaneity bias. Specifically, some of the exogenous variables
specified on the right hand side of model A and B such as per capita GDP might be jointly
correlated with per capita health expenditures, which would result in a correlation with the
error term and inconsistent estimates. Thus, OLS coefficient estimates of these variables
are clearly biased.
OLS estimation yields biased and inconsistent parameters in the presence of such
correlation. Therefore, the estimation technique that best fit the data was chosen based on
Hausman’s Chi-squared statistics, the FEM model.
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6.0 FINAL REMARKS
Using panel data with 35 OECD countries from 2000 to 2013, this paper investigates
the determinants of health expenditures. Instead of depending on cross-section regression
methods, this study employs fixed-effects panel data model based on the estimation
technique obtained from the Hausman Test.
The empirical findings presented in this paper provide empirical evidence that per
capita GDP plays a key role in explaining the cost of health care in OECD countries and that
the coefficient estimate of GDP per capita is smaller than one. This backs up the intuitive
expectation of income elasticity to be less than unity, indicating that health care is more as a
necessity than a luxury. Thus, health care expenditures are not highly income sensitive and
therefore backs up existing studies which suggest that heath care expenses are unresponsive
to changes in individual or household income.
As for non-income determinants, estimates from our regression models provide
evidence that the other key driving force of both health expenditure and health expenditure
as a share of GDP is medical progress, which are reflected in two variables, life expectancy
and population aged 65 years and older.
Besides, health resources such as the number of physicians per 1000 of population or
the number of hospital beds per 1000 of population, non-medical determinants of health care
such as alcohol and tobacco consumption, and public financing do not show any impact on
the level of health spending.
In terms of policy implications, the empirical findings highlights that health care is
not a luxury good and therefore, government should provide more support to the health care
system. Because of the income inelasticity of health care, in the market, health expenditure
is not a luxury good although the study cannot prove that it is therefore a necessary good.
Thus, those who suggest that health expenditure should have limited to none government
intervention would be going against common practice for goods that are not luxury goods.
Everyone is entitled to health care without a choice and therefore health care should be
given to people from government as many of them are unable to afford the cost of health
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care. The finding of a small income elasticity of health care expenditures implies that social
reforms aiming at cutting benefits in health care would not help reduce health care
expenditure in OECD countries. The small income elasticity of health care expenditures
found in this study demonstrates that individuals being covered by public health would
reduce the total health care expenditures.
Additionally, medical progress should receive more attention from scholars and
policy makers. In order to raise a healthier standard among the aging group, a proper
balance between spending on disease prevention and treatment should be considered as
government’s goal is to increase life expectancy while aiming for a healthier population.
Improving quality of care is also a high priority among OECD countries. As no country
consistently performs well on quality of care, there is room for improvements in all
countries in terms of health care quality and performance, prevention, and treatment of
different health problems.
Several limitations of this study need to be acknowledged. First, this study notices a
reverse causality effect between per capita GDP and per capita health care expenditures.
High levels of GDP might induce countries to spend more on health care expenditure while
at the same time when treating health as a factor of human capital and education, higher
levels health care could drive up GDP as well. This causal relationship between GDP and
health care spending leads to an endogeneity problem as it is difficult to designate a clear in
the impact of these two variables on each other. Therefore, in order to avoid reverse
causality in the model, per capita health expenditure as a share of per capita GDP is
employed as a dependent variable instead of per capita health expenditure. Second, due to
data constraints, some key factors that are not included in the model are technological
progress (R&D expenditure or CT scan are often used as a proxy), malpractice,
sociopolitical risks, or international aid. Third, only including high income countries
restricts the model sizes and make statistical inference somewhat fragile and bias.
Expanding the research paper to include both low- and middle- income countries will help
improve the quality of data and avoid misspecification in different regression models.
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Table 2. Fixed Effects Model (FEM) Regression Equations for Model A
Dependent Variable
Regression
Log of GDP per capita

Log of Health Expenditure per capita
1
2
3
0.978***
0.964***
0.924***
(6.56)
(6.66)
(6.63)

Public Financing

-0.00128
(-0.43)

-0.0011
(-0.38)

-0.00139
(-0.42)

Physicians per 1000

0.0299
1.40

0.0289
(1.34)

Hospital Beds per 1000

0.00173
(0.11)

0.00129
(0.08)

Alcohol Consumption

-0.00558
(-0.45)

-0.00503
(-0.41)

-0.00359

-0.00347

Tobacco Consumption

(-0.53)

(-0.50)

Life Expectancy

0.0342***
(2.81)

0.0375***
(2.83)

0.0389***
(2.88)

Population > 65 years old

0.0298**
(2.30)

0.0313**
(2.51)

0.0313**
(2.38)

Constant
Obs

-5.291***
490

-5.355***
490

-5.223***
490

Adjusted R2

0.82

0.82

0.82

Robust standard errors are displayed in parentheses under the coefficient estimates.
*, **, *** Denote an estimate significantly different from zero at the 10%, 5% or 1% level, respectively.
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Table 3. Fixed Effects Model (FEM) Regression Equations for Model B
Dependent Variable
Regression
Public Financing

Health Expenditure per capita as a share of GDP per capita
4
5
6
-0.000126
-0.000109
-0.000119
(-0.44)
(-0.40)
(-0.41)

Physicians per 1000

0.00204
(1.20)

0.00212
(1.21)

Hospital Beds per 1000

0.000153
(0.13)

0.0000488
(0.04)

Alcohol Consumption

-0.00034
(-0.34)

-0.000356
(-0.35)

-0.000417

-0.000409

Tobacco Consumption

(-0.72)

(-0.69)

Life Expectancy

0.00271***
(3.31)

0.00288***
(3.30)

0.00287***
(3.38)

Population > 65 years old

0.00233**
(2.71)

0.00242***
(2.91)

0.00243**
(2.72)

Constant
Obs

-0.151**
490

-0.160**
490

-0.175***
490

Adjusted R2

0.49

0.49

0.49

Robust standard errors are displayed in parentheses under the coefficient estimates.
*, **, *** Denote an estimate significantly different from zero at the 10%, 5% or 1% level, respectively.
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Table 4. OLS Test Regression Equations for Model A
Dependent Variable
Regression
Log of GDP per capita

Log of Health Expenditure per capita
1
2
3
0.811***
0.834***
0.802***
(27.37)
(27.12)
(29.15)

Public Financing

-0.00650***
(-4.71)

-0.00676***
(-4.69)

-0.00620***
(-4.52)

Physicians per 1000

0.0339***
(3.71)

0.0346***
(3.53)

Hospital Beds per 1000

-0.0102***
(-2.70)

-0.00741**
(-2.12)

Alcohol Consumption

0.0213***
(7.17)

0.0195***
(6.76)

-0.00046

-0.00325

Tobacco Consumption

(-0.20)

(-1.60)

Life Expectancy

0.0122**
(2.35)

0.0130**
(2.47)

0.00361
(0.68)

Population > 65 years old

0.0119***
(3.81)

0.0144***
(5.31)

0.0184***
(5.98)

Constant
Obs

-1.359***
490

-1.427***
490

-0.955***
490

Adjusted R2
0.91
0.91
0.91
Robust standard errors are displayed in parentheses under the coefficient estimates.
*, **, *** Denote an estimate significantly different from zero at the 10%, 5% or 1% level, respectively.
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Table 5. OLS Test Regression Equations for Model B
Dependent Variable
Regression
Public Financing

Health Expenditure per capita as a share of GDP per capita
4
5
6
-0.000814***
-0.000819***
-0.000769***
(-7.68)
(-7.43)
(-7.36)

Physicians per 1000

0.00239***
(2.83)

0.00237***
(2.87)

Hospital Beds per 1000

-0.000517
(-1.49)

-0.000504*
(-1.69)

Alcohol Consumption

0.00116***
(4.02)

0.00109***
(3.93)

-0.000198

-0.000335*

Tobacco Consumption

(-0.90)

(-1.78)

Life Expectancy

-0.00164***
(-5.23)

-0.00151***
(-4.84)

-0.00183***
(-5.67)

Population > 65 years old

0.00118***
(4.02)

0.00139***
(5.43)

0.00156***
(5.35)

Constant
Obs

0.243***
490

0.236***
490

0.257***
490

Adjusted R2

0.27

0.26

0.25

Robust standard errors are displayed in parentheses under the coefficient estimates.
*, **, *** Denote an estimate significantly different from zero at the 10%, 5% or 1% level, respectively.
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APPENDIX A: Variable Description and Data Sources
ACRONYM

PCHCE

DESCRIPTION

Per capita health care expenditures, constant prices,
constant PPPs, OECD base year, in US$

PCHCE/PCGDP Per capita health care expenditures as a share of per
capita GDP
PCGDP

DATA SOURCE

OECD Health Data Statistics

OECD Health Data
Statistics; World Bank

Gross Domestic Product per head, constant prices, World Bank
constant PPPs, in US$

PUBFIN

Proportion of total health spending financed by OECD Health Data Statistics
public expenditures

PHYS

Number of physicians per 1000 population

OECD Health Data Statistics

BED

Number of hospital beds per 1000 population

OECD Health Data Statistics

ALC

Alcohol consumption, liters per capita (age 15+)

OECD Health Data Statistics

TOB

Tobacco consumption in grams per person (age 15+)

OECD Health Data Statistics

LIFE

Life expectancy, years

OECD Health Data Statistics

POP65

Percentage of population above 65 years old

OECD Health Data Statistics
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APPENDIX B - Variables and Expected Signs
ACRONYM
PCHCE

PCHCE/PCGDP

PCGDP

PUBFIN

PHYS

BED

ALC

TOB

DEFINITION
Per capita health care expenditure
is the total cost of health care
(public and private expenditures)
Per capita health care expenditure
as a percentage of per capita
GDP is the total cost of health
care (public and private
expenditures) as a percent of per
capita GDP
GDP per capita is an aggregate
measure of production equal to
the sum of the gross values added
of all resident institutional units
engaged in production.
Government schemes and
compulsory contribution health
care financing schemes as a
percentage of total health care
spending

Practicing physicians provide
services for individual patients.

Total hospital beds are all
hospital beds which are regularly
maintained and staffed and
immediately available for the
care of admitted patients.
Annual consumption of pure
alcohol in liters, per person, aged
15 years old and over.
Annual consumption of tobacco
items (e.g. cigarettes, cigars) in
grams per person aged 15 years
old or more.
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RATIONALE

EXPECTED
SIGN

N/A

N/A

N/A

N/A

Higher income is
associated with higher
health expenditures

+

Higher percentage of
public financing will
reduce health
expenditures as
administration cost is
often reduced in a
single-payer system
Higher physicians’
density increases
health care
expenditures
Higher number of
hospital beds increase
the cost of health care

Higher alcohol
consumption implies
high health risk, thus
higher health spending
Higher tobacco
consumption leads to
poor health, therefore
driving up the rate of
health spending

-

+

+

+

+
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LIFE

POP65

Life expectancy at birth and at
various ages is the average
number of years that a person at
that age can be expected to live,
assuming that age-specific
mortality levels remain constant.
Percentage of total population
who are 65 years or older

36

Life expectancy is a
proxy of medical
progress, thus results in
lower health care
expenditures
Higher percentage of
population above 65
years old increases
health spending

+

+
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